These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 525673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ultrastructural evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats fed a low-calcium diet.
    Weisbrode SE, Capen CC, Norman AW.
    Am J Pathol; 1978 Aug; 92(2):459-72. PubMed ID: 677270
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ultrastructural evaluation of the effects of calcitonin on bone in thyroparathyroidectomized rats administered vitamin D.
    Weisbrode SE, Capen CC.
    Am J Pathol; 1974 Dec; 77(3):455-64. PubMed ID: 4611226
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The action of vitamin D metabolites (25 OHD3--12,5 (OH)2D3--24.25 (OH)2D3--25.26 (OH)2D3) on vitamin D deficient rats.
    Queille ML, Miravet L, Bordier P, Redel J.
    Biomedicine; 1978 Dec; 28(4):237-42. PubMed ID: 737274
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ultrastructural evaluation of the interaction of glucocorticoids and vitamin D on bone cells in thyroparathyroidectomized rats.
    Weisbrode SE, Capen CC.
    Am J Pathol; 1976 Sep; 84(3):457-68. PubMed ID: 961822
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of bone matrix formation, mineralization, and resorption in thyroparathyroidectomized rats.
    Wergedal J, Stauffer M, Baylink D, Rich C.
    J Clin Invest; 1973 May; 52(5):1052-8. PubMed ID: 4700483
    [Abstract] [Full Text] [Related]

  • 17. Ultrastructural development of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium.
    Boyce RW, Weisbrode SE, Kindig O.
    Bone; 1985 May; 6(3):165-72. PubMed ID: 3839678
    [Abstract] [Full Text] [Related]

  • 18. Effect of hydrochlorothiazide on 1,25-dihydroxyvitamin D3-induced changes in calcium metabolism in experimental hypoparathyroidism in rats.
    Rizzoli R, Hugi K, Fleisch H, Bonjour JP.
    Clin Sci (Lond); 1981 Jan; 60(1):101-7. PubMed ID: 6894567
    [Abstract] [Full Text] [Related]

  • 19. [Effect of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth and remodeling of rat bones during hypokinesia (histomorphometric study)].
    Kabitskaia OE, Savik ZF, Kaplanskiĭ AS, Shvets VN, Sergeev IN.
    Kosm Biol Aviakosm Med; 1984 Jan; 18(4):49-55. PubMed ID: 6332944
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.